Corporate VC (CVC)

What is CVC?

CVC stands for corporate venture capital: a venture investing arm funded by an operating company rather than by outside limited partners. The parent supplies the capital and usually the strategic agenda, so the investment is judged on financial return and on what it does for the parent's business.

How a CVC differs from an independent fund

Four structural differences do most of the work.

• One limited partner. GV describes Alphabet as its sole limited partner, which is the defining CVC feature: no fundraising cycle, no LP base to diversify, and a single decision-maker who can change the mandate.
• Balance-sheet capital rather than a fixed-life fund. Many CVCs invest from the parent's balance sheet with an annual budget, so there is no ten-year term forcing exits and no committed pool that survives a change of strategy.
• A strategic return alongside the financial one. The parent is buying market intelligence, partnership options and a view of potential acquisitions as well as equity.
• Compensation that rarely includes conventional carry. Investment teams are usually on corporate pay, which changes incentives on both selection and exit timing.

Scale is real. GV launched as Google Ventures in 2009 with a $60 million capital commitment and states that it now has over $13 billion in assets under management supporting 400 active portfolio companies across North America, Europe and Israel. Salesforce Ventures states that since its founding in 2009 it has invested in more than 630 startups, deployed $6 billion or more in capital, and guided over 200 companies to IPOs and acquisitions.

How big is corporate venture investing

CB Insights, in its State of CVC 2024 report, found global CVC-backed funding of $65.9 billion, a 20 percent year-over-year increase, with the US as the main driver at $42.8 billion, up 39 percent. The same report found the average deal size among deals with CVC participation reached $27.3 million, a 34 percent increase and tied for the second highest level on record, while deal count fell to 3,434, the lowest in six years. Early-stage rounds, meaning seed, angel and Series A, made up 65 percent of CVC-backed deals, tied for the highest share recorded in more than a decade.

The shape of that data is the useful part: fewer deals, bigger checks, concentrated earlier than the stereotype suggests. Corporate investors are not only late-stage strategic money.

They also show up alongside each other. Harvey's $300 million Series D, announced February 12, 2025 at a $3 billion valuation and led by Sequoia, included GV and REV, the venture arm of RELX Group, which owns LexisNexis. Two corporate vehicles, one of them owned by a direct incumbent in the buyer's own market, in a single round.

What the startup gets, and gives up

The gets are concrete when the parent actually delivers: named customer introductions, a reseller or marketplace listing, technical integration help, credibility with enterprise buyers who want to know the platform will still exist, and a relationship with a plausible acquirer.

The gives up are just as concrete.

• Signaling. A strategic investor on the cap table tells that corporate's competitors which way the company leans, which can close doors at other potential partners and buyers.
• Information rights in a competitor's hands. A corporate investor with board observer rights and quarterly reporting sees roadmap and revenue detail that its operating divisions would pay for.
• Exit friction. Rights of first refusal, rights of first offer or notice provisions favoring the corporate can narrow the buyer field later, which is where the term sheet deserves the most attention.
• Mandate risk. A parent that reorganizes, changes CEO or cuts budget can stop supporting the relationship, and unlike a fund with a ten-year term, there is no committed capital obliging it to continue.

Worked example

The figures below are hypothetical and chosen so the arithmetic can be checked.

A company raises a $15 million Series B at a $200 million post-money valuation from a corporate investor. Dilution is $15 million divided by $200 million, which is 7.5 percent. A founder group holding 30 percent before the round holds 30 percent times 0.925, which is 27.75 percent after.

Step one, the cost of the dilution to the founders. They gave up 30 percent times 7.5 percent, which is 2.25 percentage points of the company. At the $200 million post-money valuation, 2.25 percent is $4.5 million of value.

Step two, the strategic benefit, quantified. Suppose the partnership that comes with the money produces $4 million of incremental annual recurring revenue that the company would not otherwise have won, and the company is valued at 6 times revenue. That is $24 million of added enterprise value.

Step three, the founders' share of the benefit. After the round they hold 27.75 percent, and 27.75 percent of $24 million is about $6.66 million.

Step four, the net. $6.66 million of benefit against $4.5 million of dilution cost is roughly $2.16 million positive. The strategic premium is worth taking in this example, but the margin is thin enough that if the partnership delivers half of what was promised, or the revenue multiple compresses to 4 times, the trade goes the other way.

That is the discipline the arithmetic imposes: strategic value has to be estimated in dollars and compared with dilution, not accepted as a qualitative bonus. Ask for the partnership terms in writing in the same week as the term sheet, because a commercial agreement signed before the wire is evidence and one promised after it is a hope.

Common mistakes

• Taking strategic money for the logo. Validation with enterprise buyers is real but it is worth less than a signed distribution agreement.
• Granting exit-restricting rights. A right of first refusal or a first-look provision for a corporate investor can quietly reduce the number of bidders in a future sale.
• Assuming the parent is one buyer. The venture arm and the business unit are different organizations with different incentives, and the arm cannot commit the unit.
• Ignoring competitive reach-through. If the corporate's divisions compete with several of the company's partners, the cap table entry is a strategic disclosure.
• Treating the check as permanent capital. Budgets are annual, mandates change, and follow-on support from a CVC is less predictable than from a fund with committed reserves.

Related terms

A strategic investor is the broader category a CVC belongs to, and corporate venture capital is the same concept written out. A strategic acquirer is what many corporate investors hope to become to their portfolio companies, which is why exit provisions matter so much in the financing documents. The lead investor question is separate: a corporate can lead, but many founders prefer a financial lead setting price and a corporate taking a minority of the round. Signaling risk is the cost that shows up later, when the next round's buyers read the cap table.